Continue reading...
CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
，推荐阅读搜狗输入法2026获取更多信息
更多详细新闻请浏览新京报网 www.bjnews.com.cn
// ... 还有一个方向相反的光